{
"id":"mk19_bb_cv_s2",
"subspecialtyId":"cv",
"title":"Acute Coronary Syndromes (STEMI, NSTE-ACS)",
"jsonContent":{
"type":"section",
"id":"mk19_bb_cv_s2",
"title":{
"__html":"Acute Coronary Syndromes (STEMI, NSTE-ACS)"
},
"titleNode":{
"type":"section-title",
"hlId":"5853ea",
"children":[
"Acute Coronary Syndromes (STEMI, NSTE-ACS)"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_cv_s2_0",
"children":[
{
"type":"p",
"hlId":"e01845",
"children":[
"Acute coronary syndromes occur when coronary blood flow is disrupted or metabolic requirements exceed supply."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_cv_s2_1",
"title":{
"__html":"Testing"
},
"titleNode":{
"type":"section-title",
"hlId":"fa6a5a",
"children":[
"Testing"
]
},
"children":[
{
"type":"p",
"hlId":"e5fe27",
"children":[
"The 12-lead ",
{
"type":"abbreviation",
"title":"electrocardiogram",
"children":[
"ECG"
]
},
" and serum biomarkers distinguish three types of ",
{
"type":"abbreviation",
"title":"acute coronary syndrome",
"children":[
"ACS"
]
},
":"
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_bb_cv_s2_inline_t1"
],
"forceOpen":true
},
{
"type":"p",
"hlId":"317748",
"children":[
"Echocardiogram may show regional wall motion abnormalities in ACS when the diagnosis is not clear."
]
},
{
"type":"p",
"hlId":"8fe3eb",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Unstable Angina/"
]
},
{
"type":"abbreviation",
"title":"non–ST-elevation myocardial infarction",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"NSTEMI"
]
}
]
}
]
},
{
"type":"p",
"hlId":"0c9a3d",
"children":[
"In patients with ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"unstable angina/NSTEMI"
]
},
", immediate angiography is indicated if any of the following are present:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"5cd36d",
"children":[
"hemodynamic instability"
]
},
" ",
{
"type":"list-item",
"hlId":"5d16f8",
"children":[
" ",
{
"type":"abbreviation",
"title":"heart failure",
"children":[
"HF"
]
},
" "
]
},
" ",
{
"type":"list-item",
"hlId":"cf2c7d",
"children":[
"recurrent rest angina despite therapy"
]
},
" ",
{
"type":"list-item",
"hlId":"21f665",
"children":[
"new or worsening ",
{
"type":"abbreviation",
"title":"mitral regurgitation",
"children":[
"MR"
]
},
" murmur"
]
},
" ",
{
"type":"list-item",
"hlId":"723c49",
"children":[
"sustained ",
{
"type":"abbreviation",
"title":"ventricular tachycardia",
"children":[
"VT"
]
}
]
},
" "
]
},
{
"type":"p",
"hlId":"d01c12",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Risk stratification:"
]
},
" In patients with unstable angina and NSTEMI, risk stratification is used to determine whether the patient should receive early angiography or predischarge stress testing with angiography if significant ischemia is present. Several risk scoring systems are available. One is the Thrombolysis in Myocardial Infarction (TIMI) risk score. The risk of death from ",
{
"type":"abbreviation",
"title":"myocardial infarction",
"children":[
"MI"
]
},
" significantly increases with a higher ",
{
"type":"abbreviation",
"title":"Thrombolysis in Myocardial Infarction (risk score)",
"children":[
"TIMI"
]
},
" risk score."
]
},
{
"type":"p",
"hlId":"e0c191",
"children":[
" ",
{
"type":"alert",
"children":[
"Do not memorize the scoring system, but understand the difference in approach for a patient with a low risk score, such as a TIMI score of 0 to 2, compared with the approach for a patient with a higher score (3-7)."
]
},
" "
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_bb_cv_s2_inline_t2"
],
"forceOpen":true
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"aa4d7f",
"children":[
{
"type":"alert",
"children":[
{
"type":"abbreviation",
"title":"ST-elevation myocardial infarction",
"children":[
"STEMI"
]
},
" is not the only cause of ST-segment elevations."
]
},
" Consider acute pericarditis, ",
{
"type":"abbreviation",
"title":"left ventricular",
"children":[
"LV"
]
},
" aneurysm, stress (takotsubo) cardiomyopathy, coronary vasospasm, acute stroke, or normal variant."
]
},
" "
]
},
{
"type":"p",
"hlId":"56b7c4",
"children":[
" ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"STEMI"
]
},
" "
]
},
{
"type":"p",
"hlId":"fc8cc5",
"children":[
"In patients with ischemic symptoms for less than 12 hours, percutaneous coronary intervention (PCI) should be performed to improve survival. In patients with cardiogenic shock or hemodynamic instability, ",
{
"type":"abbreviation",
"title":"percutaneous coronary intervention",
"children":[
"PCI"
]
},
" or ",
{
"type":"abbreviation",
"title":"coronary artery bypass graft",
"children":[
"CABG"
]
},
" (when PCI is not feasible) is indicated to improve survival, irrespective of the time from MI onset. PCI should be performed as soon as possible, with first medical contact to PCI time ≤90 minutes in a PCI-capable hospital and ≤120 minutes if transferred from a non–PCI-capable hospital to a PCI-capable hospital."
]
},
{
"type":"p",
"hlId":"d4b966",
"children":[
"After successful PCI of the culprit vessel in selected hemodynamically stable patients with multivessel disease, staged PCI of a significant noninfarct artery stenosis is recommended within a short interval (days to weeks) to reduce the risk of death or MI."
]
},
{
"type":"p",
"hlId":"0aaa32",
"children":[
"Other indications for PCI are:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"54604e",
"children":[
"failure of thrombolytic therapy"
]
},
" ",
{
"type":"list-item",
"hlId":"232c80",
"children":[
"new HF or cardiogenic shock"
]
},
" "
]
},
{
"type":"p",
"hlId":"95b735",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Thrombolytic agents:"
]
},
" Administer thrombolytic agents when PCI is not available and cannot be achieved within 120 minutes with transfer. The most commonly encountered contraindications include active bleeding or high risk for bleeding (recent major surgery). ",
{
"type":"abbreviation",
"title":"blood pressure",
"children":[
"BP"
]
},
" >180/110 mm Hg is a contraindication, but if the blood pressure is lowered, treatment is possible."
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_bb_cv_s2_inline_t3"
],
"forceOpen":true
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"225c1a",
"children":[
"Do not choose thrombolytic therapy for patients with NSTEMI or for asymptomatic patients with onset of pain >24 hours ago."
]
},
" ",
{
"type":"list-item",
"hlId":"e17296",
"children":[
"Although guidelines define minimum dual antiplatelet duration, the optimal duration should be individualized according to the patient's risks for thrombotic and bleeding complications."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_cv_s2_2",
"title":{
"__html":"Pacing in Acute MI"
},
"titleNode":{
"type":"section-title",
"hlId":"484276",
"children":[
"Pacing in Acute MI"
]
},
"children":[
{
"type":"p",
"hlId":"039983",
"children":[
"Recommendations for temporary pacing in the setting of acute MI are:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"f0b3aa",
"children":[
"symptomatic bradycardia (including complete heart block)"
]
},
" ",
{
"type":"list-item",
"hlId":"2639c0",
"children":[
"alternating ",
{
"type":"abbreviation",
"title":"left bundle branch block",
"children":[
"LBBB"
]
},
" and ",
{
"type":"abbreviation",
"title":"right bundle branch block",
"children":[
"RBBB"
]
}
]
},
" ",
{
"type":"list-item",
"hlId":"32eb74",
"children":[
"new or indeterminate-age bifascicular block with first-degree ",
{
"type":"abbreviation",
"title":"atrioventricular",
"children":[
"AV"
]
},
" block"
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_cv_s2_3",
"title":{
"__html":"Complications of Acute MI"
},
"titleNode":{
"type":"section-title",
"hlId":"444d95",
"children":[
"Complications of Acute MI"
]
},
"children":[
{
"type":"p",
"hlId":"c6a03d",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Right ventricular infarction:"
]
},
" Patients with a right ventricular/posterior infarction ",
{
"type":"alert",
"children":[
"may present with hypotension or may develop hypotension following the administration of nitroglycerin or morphine."
]
},
" Look for ",
{
"type":"abbreviation",
"title":"jugular venous distention",
"children":[
"JVD"
]
},
" with clear lungs, hypotension, and tachycardia. The most predictive ECG finding is ST-segment elevation on right-sided ECG lead V",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"4"
]
},
"R. ",
{
"type":"alert",
"children":[
"Treat with IV fluids."
]
}
]
},
{
"type":"p",
"hlId":"aa73d7",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Mechanical complications"
]
},
" (",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"ventricular septal defect",
"children":[
"VSD"
]
},
","
]
},
" papillary muscle rupture, and LV free wall rupture) may occur 2 to 7 days after an MI. Emergency echocardiography is the initial diagnostic study. Patients with VSD or papillary muscle rupture develop abrupt pulmonary edema or hypotension and a loud holosystolic murmur and thrill. LV free wall rupture causes sudden hypotension or cardiac death associated with pulseless electrical activity."
]
},
{
"type":"p",
"hlId":"ae8e1b",
"children":[
"Patients with papillary muscle rupture and VSD should be stabilized with an intra-aortic balloon pump, afterload reduction with sodium nitroprusside, and diuretics followed by emergency surgical intervention."
]
},
{
"type":"p",
"hlId":"c303e1",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Cardiogenic shock:"
]
},
" Emergency revascularization supported by intra-aortic balloon pump and ",
{
"type":"abbreviation",
"title":"left ventricular assist device",
"children":[
"LVAD"
]
},
" may be necessary."
]
},
{
"type":"p",
"hlId":"7f2240",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Postinfarction angina:"
]
},
" Cardiac catheterization is indicated."
]
},
{
"type":"p",
"hlId":"486e4b",
"children":[
"In patients with recurrent ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"ventricular arrhythmias"
]
},
", an underlying cause, such as recurrent ischemia, should be sought."
]
},
{
"type":"p",
"hlId":"7528f9",
"children":[
" ",
{
"type":"alert",
"children":[
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"implantable cardioverter defibrillator",
"children":[
"ICD"
]
},
"s"
]
},
" are indicated in post-MI patients meeting all of the following criteria:"
]
},
" "
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"553d8c",
"children":[
">40 days since MI or >3 months since PCI or CABG"
]
},
" ",
{
"type":"list-item",
"hlId":"cf1538",
"children":[
{
"type":"abbreviation",
"title":"left ventricular ejection fraction",
"children":[
"LVEF"
]
},
" ≤35% and ",
{
"type":"abbreviation",
"title":"New York Heart Association",
"children":[
"NYHA"
]
},
" functional class II or III or LVEF ≤30% and NYHA functional class I"
]
},
" "
]
},
{
"type":"p",
"hlId":"86e48d",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Depression:"
]
},
" All post-MI patients should be screened for depression, because it is associated with increased hospitalization and death."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_cv_s2_4",
"title":{
"__html":"Test Yourself"
},
"titleNode":{
"type":"section-title",
"hlId":"7866cc",
"children":[
"Test Yourself"
]
},
"children":[
{
"type":"p",
"hlId":"885176",
"class":"test",
"children":[
"A 56-year-old woman has a 3-hour history of chest pain. BP is 80/60 mm Hg, respiration rate is 30/min, and pulse rate is 120/min. Physical examination shows JVD, inspiratory crackles, and an S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"3"
]
},
" gallop. ECG shows 2-mm ST-segment elevation in leads V",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" to V",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"6"
]
},
"."
]
},
{
"type":"p",
"hlId":"4544c7",
"class":"test_answer",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Answer:"
]
},
" ",
"For diagnosis, choose STEMI and cardiogenic shock. For management, choose cardiac catheterization and PCI."
]
},
{
"type":"p",
"hlId":"160103",
"class":"test",
"children":[
"A 58-year-old man with acute chest pain has ST-segment elevation in leads II, III, and aVF. BP is 82/52 mm Hg, and pulse rate is 54/min. Physical examination shows JVD, clear lungs, and no murmur or S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"3"
]
},
"."
]
},
{
"type":"p",
"hlId":"18e423",
"class":"test_answer",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Answer:"
]
},
" ",
"For diagnosis, choose ",
{
"type":"abbreviation",
"title":"right ventricular",
"children":[
"RV"
]
},
" MI. For management, select IV fluids, ECG lead V",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"4"
]
},
"R tracing, and cardiac catheterization."
]
},
{
"type":"inline-wrap",
"wrapId":"4",
"contentIds":[
"mk19_bb_cv_f01"
],
"forceOpen":true
},
{
"type":"inline-wrap",
"wrapId":"5",
"contentIds":[
"mk19_bb_cv_f02"
],
"forceOpen":true
}
]
},
{
"type":"section",
"id":"mk19_bb_cv_s2_5",
"title":{
"__html":"Follow-up"
},
"titleNode":{
"type":"section-title",
"hlId":"b9c20d",
"children":[
"Follow-up"
]
},
"children":[
{
"type":"p",
"hlId":"8f9582",
"children":[
"Arrange for cardiac rehabilitation. Medications at hospital discharge should include aspirin indefinitely, a P2Y",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"12"
]
},
" inhibitor for at least 1 year, a β-blocker, a statin, and an ",
{
"type":"abbreviation",
"title":"angiotensin-converting enzyme",
"children":[
"ACE"
]
},
" inhibitor or ",
{
"type":"abbreviation",
"title":"angiotensin receptor blocker",
"children":[
"ARB"
]
},
" (in patients with LV systolic dysfunction, hypertension, diabetes, or kidney disease)."
]
}
]
}
]
},
"tablesContent":{
"mk19_bb_cv_s2_inline_t1":{
"id":"mk19_bb_cv_s2_inline_t1",
"number":1,
"bookId":"cv",
"title":{
"__html":"Study Table: Diagnosis of ACS in Patients With Chest Pain"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"fc3d4f",
"children":[
"Study Table: Diagnosis of ACS in Patients With Chest Pain"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"48d8d6",
"class":"col hd l",
"children":[
"Syndrome"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b5a7ad",
"class":"col hd l",
"children":[
"Description"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"519506",
"class":"cell txt l",
"children":[
{
"type":"abbreviation",
"title":"non–ST-elevation acute coronary syndrome",
"children":[
"NSTE-ACS"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0b28c9",
"class":"cell txt li",
"children":[
"Unstable angina"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bd5abe",
"class":"cell txt l",
"children":[
" ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Normal cardiac biomarkers"
]
},
" "
]
},
" ",
{
"type":"p",
"hlId":"98f226",
"class":"cell txt l",
"children":[
"May have nonspecific ECG changes, ST-segment depression, or T-wave inversion"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5f7e71",
"class":"cell txt li",
"children":[
"NSTEMI"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4d891d",
"class":"cell txt l",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Positive biomarkers"
]
},
" without ST elevations or ST-elevation equivalents"
]
},
" ",
{
"type":"p",
"hlId":"121e31",
"class":"cell txt l",
"children":[
"May have nonspecific ECG changes, ST-segment depression, and T-wave inversion"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"02d771",
"class":"cell txt l",
"children":[
"STEMI"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f900d6",
"class":"cell txt l",
"children":[
"ST-segment elevation of ≥1 mm in ≥2 contiguous limb or chest leads, although ST-segment elevation in leads V",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" and V",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"3"
]
},
" must be ≥2 mm in men and ≥1.5 mm in women"
]
},
" ",
{
"type":"p",
"hlId":"860b47",
"class":"cell txt l",
"children":[
"ST-elevation equivalents include new LBBB or posterior MI (tall R waves and ST depressions in V",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
},
"-V",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"4"
]
},
")"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_bb_cv_s2_inline_t2":{
"id":"mk19_bb_cv_s2_inline_t2",
"number":2,
"bookId":"cv",
"title":{
"__html":"Study Table: Unstable Angina or NSTEMI Risk Stratification "
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"7537af",
"children":[
"Study Table: Unstable Angina or NSTEMI Risk Stratification "
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"db5299",
"class":"col hd l",
"children":[
"TIMI Risk Score"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"83de19",
"class":"col hd l",
"children":[
"Strategy"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dfbffa",
"class":"cell txt l",
"children":[
"0-2"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"16b176",
"class":"cell txt l",
"children":[
"Low risk. Begin aspirin, β-blocker, nitrates, heparin, statin, clopidogrel. Predischarge stress testing and angiography if testing reveals significant myocardial ischemia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e30609",
"class":"cell txt l",
"children":[
"3-7"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"83f902",
"class":"cell txt l",
"children":[
"Intermediate to high risk. Begin aspirin, β-blocker, nitrates, heparin, statin, clopidogrel, and early revascularization"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_bb_cv_s2_inline_t3":{
"id":"mk19_bb_cv_s2_inline_t3",
"number":3,
"bookId":"cv",
"title":{
"__html":"Study Table: Drug Therapy for ACS"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"51aecc",
"children":[
"Study Table: Drug Therapy for ACS"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5db77f",
"class":"col hd l",
"children":[
"Drug"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1b1583",
"class":"col hd l",
"children":[
"Indication"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c40028",
"class":"cell txt l",
"children":[
"Aspirin"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"69b9cc",
"class":"cell txt l",
"children":[
"ASAP for all patients with ACS"
]
},
" ",
{
"type":"p",
"hlId":"a1ca71",
"class":"cell txt l",
"children":[
"Continue indefinitely as secondary prevention"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bb80fa",
"class":"cell txt l",
"children":[
"P2Y",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"12"
]
},
" inhibitor (clopidogrel, ticagrelor, or prasugrel in patients with ACS treated with PCI)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"69b9cc",
"class":"cell txt l",
"children":[
"ASAP for all patients with ACS"
]
},
" ",
{
"type":"p",
"hlId":"5f7937",
"class":"cell txt l",
"children":[
"Prasugrel contraindicated in patients age ≥75 years or history of ",
{
"type":"abbreviation",
"title":"cerebrovascular accident",
"children":[
"CVA"
]
},
"/",
{
"type":"abbreviation",
"title":"transient ischemic attack",
"children":[
"TIA"
]
}
]
},
" ",
{
"type":"p",
"hlId":"a60806",
"class":"cell txt l",
"children":[
"Continue for at least 1 year following MI in most patients"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ab36e2",
"class":"cell txt l",
"children":[
"β-Blockers (metoprolol, carvedilol)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1ada8d",
"class":"cell txt l",
"children":[
"Administer for ACS within 24 hours"
]
},
" ",
{
"type":"p",
"hlId":"a1ca71",
"class":"cell txt l",
"children":[
"Continue indefinitely as secondary prevention"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"aedc01",
"class":"cell txt l",
"children":[
"Anticoagulant (",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"unfractionated heparin",
"children":[
"UFH"
]
},
","
]
},
" ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"low-molecular-weight heparin",
"children":[
"LMWH"
]
},
","
]
},
" fondaparinux)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d3aabf",
"class":"cell txt l",
"children":[
"ASAP for definite or likely ACS. Choice depends on reperfusion strategy. Any can be used with thrombolytic therapy. UFH is preferred for PCI, and fondaparinux should be avoided."
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"10b7d4",
"class":"cell txt l",
"children":[
"ACE inhibitors"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e409ec",
"class":"cell txt l",
"children":[
"Administer within 24 hours"
]
},
" ",
{
"type":"p",
"hlId":"23b987",
"class":"cell txt l",
"children":[
"Continue indefinitely in patients with reduced LVEF or clinical HF, diabetes, hypertension, or ",
{
"type":"abbreviation",
"title":"chronic kidney disease",
"children":[
"CKD"
]
}
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d63083",
"class":"cell txt l",
"children":[
"ARB"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"971a83",
"class":"cell txt l",
"children":[
"Administer if intolerant of ACE inhibitor"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9936ff",
"class":"cell txt l",
"children":[
"Nitroglycerin"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bbdd70",
"class":"cell txt l",
"children":[
"Administer in presence of ongoing chest pain or HF"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7b8abf",
"class":"cell txt l",
"children":[
"Statin"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"44d93a",
"class":"cell txt l",
"children":[
"Administer high-intensity statin early, even in patients with low ",
{
"type":"abbreviation",
"title":"low-density lipoprotein",
"children":[
"LDL"
]
},
" levels"
]
},
" ",
{
"type":"p",
"hlId":"a1ca71",
"class":"cell txt l",
"children":[
"Continue indefinitely as secondary prevention"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f5dfbe",
"class":"cell txt l",
"children":[
"Eplerenone"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cf416e",
"class":"cell txt l",
"children":[
"Administer 3 to 14 days after MI if LVEF ≤40% and clinical HF or diabetes"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
}
}
}